Raimondi, I. (Iván)

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element
    (2017) Grossi, E. (Elena); Gonzalez-Rojas, S.J. (Sandra Jovanna); Guo, S. (Shuling); Martínez, D. (Dannys); Rouzaut, A. (Ana); Marin-Bejar, O. (Oskar); Athie-Cuervo, A. (Alejandro); Ulitsky, I. (Igor); Huarte-Martínez, M. (Maite); Raimondi, I. (Iván); Morales-Urteaga, X. (Xabier); Galduroz, M. (Mikel); Mas, A. (Aina)
    Background: It is now obvious that the majority of cellular transcripts do not code for proteins, and a significant subset of them are long non-coding RNAs (lncRNAs). Many lncRNAs show aberrant expression in cancer, and some of them have been linked to cell transformation. However, the underlying mechanisms remain poorly understood and it is unknown how the sequences of lncRNA dictate their function. Results: Here we characterize the function of the p53-regulated human lncRNA LINC-PINT in cancer. We find that LINC-PINT is downregulated in multiple types of cancer and acts as a tumor suppressor lncRNA by reducing the invasive phenotype of cancer cells. A cross-species analysis identifies a highly conserved sequence element in LINC-PINT that is essential for its function. This sequence mediates a specific interaction with PRC2, necessary for the LINC-PINT-dependent repression of a pro-invasion signature of genes regulated by the transcription factor EGR1. Conclusions: Our findings support a conserved functional co-dependence between LINC-PINT and PRC2 and lead us to propose a new mechanism where the lncRNA regulates the availability of free PRC2 at the proximity of co-regulated genomic loci.
  • Thumbnail Image
    Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion
    (Rockefeller University Pres, 2020) Pajares, M.J. (María José); Gonzalez-Rojas, S.J. (Sandra Jovanna); Kanduri, C. (Chandrasekhar); Martínez, D. (Dannys); Lozano-Moreda, T. (Teresa); Kumar-Juvvuna, P. (Prasanna); Marin-Bejar, O. (Oskar); Athie-Cuervo, A. (Alejandro); Montuenga-Badia, L.M. (Luis M.); Huarte-Martínez, M. (Maite); Raimondi, I. (Iván); Abad, A. (Amaya); Marchese, F.P. (Francesco P.); Ajona, D. (Daniel); Serizay, J. (Jacques); Sandoval, J. (Juan); Lasarte, J.J. (Juan José)
    Cancer is characterized by genomic instability leading to deletion or amplification of oncogenes or tumor suppressors. However, most of the altered regions are devoid of known cancer drivers. Here, we identify lncRNAs frequently lost or amplified in cancer. Among them, we found amplified lncRNA associated with lung cancer-1 (ALAL-1) as frequently amplified in lung adenocarcinomas. ALAL-1 is also overexpressed in additional tumor types, such as lung squamous carcinoma. The RNA product of ALAL-1 is able to promote the proliferation and tumorigenicity of lung cancer cells. ALAL-1 is a TNFα− and NF-κB–induced cytoplasmic lncRNA that specifically interacts with SART3, regulating the subcellular localization of the protein deubiquitinase USP4 and, in turn, its function in the cell. Interestingly, ALAL-1 expression inversely correlates with the immune infiltration of lung squamous tumors, while tumors with ALAL-1 amplification show lower infiltration of several types of immune cells. We have thus unveiled a pro-oncogenic lncRNA that mediates cancer immune evasion, pointing to a new target for immune potentiation.
  • Thumbnail Image
    A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions
    (Springer Nature, 2020) Grossi, E. (Elena); Goñi, E. (Enrique); Gonzalez-Rojas, S.J. (Sandra Jovanna); Guo, S. (Shuling); Chapaprieta, V. (Vicente); Huarte-Martínez, M. (Maite); Raimondi, I. (Iván); Marchese, F.P. (Francesco P.); Martin-Subero, J.I. (Jose Ignacio)
    LncRNAs have been shown to be direct players in chromatin regulation, but little is known about their role at active genomic loci. We investigate the role of lncRNAs in gene activation by profiling the RNA interactome of SMARCB1-containing SWI/SNF complexes in proliferating and senescent conditions. The isolation of SMARCB1-associated transcripts, together with chromatin profiling, shows prevalent association to active regions where SMARCB1 differentially binds locally transcribed RNAs. We identify SWINGN, a lncRNA interacting with SMARCB1 exclusively in proliferating conditions, exerting a pro-oncogenic role in some tumor types. SWINGN is transcribed from an enhancer and modulates the activation of GAS6 oncogene as part of a topologically organized region, as well as a larger network of pro-oncogenic genes by favoring SMARCB1 binding. Our results indicate that SWINGN influences the ability of the SWI/SNF complexes to drive epigenetic activation of specific promoters, suggesting a SWI/SNF-RNA cooperation to achieve optimal transcriptional activation.